Key result
Remimazolam significantly reduced the risk of post-induction hypotension compared to propofol (RR 0.57) in patients undergoing surgery under general anesthesia.
Why the study?
To compare the risk of hypotension, as well as induction and recovery characteristics, between remimazolam and propofol in patients undergoing surgery under general anesthesia.
Does remimazolam reduce post-induction hypotension compared to propofol in adult patients receiving surgery under general anesthesia?
Population
738 patients receiving surgery under general anesthesia across eight studies
Comparison
Remimazolam vs propofol
Design
Systematic review and meta-analysis of randomized controlled trials
Authors
Loading...
Remimazolam may lower post-induction hypotension risk versus propofol; extends RCT evidence for safer general anesthesia induction.
Meta-Analysis (n=738)
Does remimazolam reduce post-induction hypotension compared to propofol in adult patients receiving surgery under general anesthesia?
Relative Risk: 0.57 (95% CI 0.43–0.75)
Absolute Event Rate: 27.4% vs 42.4%
p-value: p=<0.0001
Remimazolam provides a safer hemodynamic profile with a significantly lower risk of post-induction hypotension and injection pain compared to propofol, while maintaining similar recovery characteristics.
Ko et al. (2023) conducted a meta-analysis in General anesthesia (n=738). Remimazolam vs. Propofol was evaluated on Risk of post-induction hypotension (RR 0.57, 95% CI 0.43 to 0.75, p=<0.0001). Remimazolam significantly reduced the risk of post-induction hypotension compared to propofol (RR 0.57) in patients undergoing surgery under general anesthesia.
Synapse has enriched 5 closely related papers on similar clinical questions. Consider them for comparative context: